These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 8583701)

  • 1. Clinical effect of the anti-platelet drug, dilazep dihydrochloride, in patients at the microalbuminuric stage of diabetic nephropathy--a multi-center study.
    Koide H; Totsuka Y; Sugisaki T; Kitajima T; Ohmori Y; Kuriyama S; Oi K; Isogai S; Ohi H; Tomino Y
    Nihon Jinzo Gakkai Shi; 1995 Nov; 37(11):644-8. PubMed ID: 8583701
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silent cerebral infarction in patients with type 2 diabetic nephropathy. Effects of antiplatelet drug dilazep dihydrochloride.
    Nakamura T; Kawagoe Y; Matsuda T; Ueda Y; Ebihara I; Koide H
    Diabetes Metab Res Rev; 2005; 21(1):39-43. PubMed ID: 15386824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the antiplatelet drug dilazep dihydrochloride on urinary podocytes in patients in the early stage of diabetic nephropathy.
    Nakamura T; Ushiyama C; Shimada N; Sekizuka K; Ebihara I; Hara M; Koide H
    Diabetes Care; 2000 Aug; 23(8):1168-71. PubMed ID: 10937516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dilazep hydrochloride, an antiplatelet drug, prevents progression of diabetic nephropathy in Otsuka Long-Evans Tokushima fatty rats.
    Yamagishi S; Koga K; Inagaki Y; Amano S; Okamoto T; Takeuchi M
    Drugs Exp Clin Res; 2002; 28(6):221-7. PubMed ID: 12776575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of an anti-platelet drug (dilazep) in IgA nephropathy: comparison of clinical effects with renal biopsy findings.
    Yoshida H; Kanatsu K; Muso E; Kuwahara T; Sekita K; Ono T; Konishi N; Kanda C; Minakata T; Morimoto K
    Nihon Jinzo Gakkai Shi; 1994 Apr; 36(4):339-44. PubMed ID: 8022106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of dilazep dihydrochloride on urinary albumin excretion in patients with autosomal dominant polycystic kidney disease.
    Nakamura T; Ushiyama C; Takahashi Y; Tanaka A; Shimada N; Ebihara I; Koide H
    Nephron; 2001 May; 88(1):80-2. PubMed ID: 11340355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal protection and angiotensin converting enzyme inhibition in microalbuminuric type I and type II diabetic patients.
    Cooper ME
    J Hypertens Suppl; 1996 Dec; 14(6):S11-4. PubMed ID: 9023709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of sulodexide on albuminuria, NAG excretion and glomerular filtration response to dopamine in diabetic patients.
    Sulikowska B; Olejniczak H; Muszyńska M; Odrowaz-Sypniewska G; Gaddi A; Savini C; Cicero AF; Laghi L; Manitius J
    Am J Nephrol; 2006; 26(6):621-8. PubMed ID: 17191008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of enalapril and nitrendipine on exercise albuminuria in normotensive type I diabetic patients with incipient nephropathy.
    Heinemann L; Janicke I; Bender R; Berger M; Sawicki PT
    Horm Metab Res; 1996 Oct; 28(10):549-52. PubMed ID: 8934214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of decreased albuminuria caused by angiotensin converting enzyme inhibitor in early diabetic nephropathy.
    Imanishi M; Yoshioka K; Okumura M; Konishi Y; Tanaka S; Fujii S; Kimura G
    Kidney Int Suppl; 1997 Dec; 63():S198-200. PubMed ID: 9407458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Albuminuria induced by exercise in hypertensive type I and type II diabetic patients: a randomised, double-blind study on the effects of acute administration of captopril and nifedipine.
    Romanelli G; Giustina A; Cravarezza P; Caldonazzo A; Agabiti-Rosei E; Giustina G
    J Hum Hypertens; 1991 Jun; 5(3):167-73. PubMed ID: 1920340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term clinical trial of 1-(1-[4-(3-acetylaminopropoxy)-benzoyl]-4-piperidyl)-3, 4-dihydro-2(1H)-quinolinone in patients with diabetic nephropathy. Possible effectiveness of the specific vasopressin V1 receptor antagonist for reducing albuminuria in patients with non-insulin dependent diabetes mellitus.
    Nishikawa T; Omura M; Iizuka T; Saito I; Yoshida S
    Arzneimittelforschung; 1996 Sep; 46(9):875-8. PubMed ID: 8876935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of long-term administration of picotamide on baseline and exercise-induced urinary albumin excretion in patients with type II diabetes mellitus and incipient nephropathy.
    Giustina A; Ianniello P; Bossoni S; Comini MT; Desenzani P; Gazzoli N; Romanelli G
    Clin Ther; 1994; 16(2):191-9. PubMed ID: 8062315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
    de Zeeuw D
    Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of losartan in reducing microalbuminuria in normotensive patients with type-2 diabetes mellitus.
    Agha A; Bashir K; Anwar E
    Nepal Med Coll J; 2007 Jun; 9(2):79-83. PubMed ID: 17899953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of dilazep on circulating platelet aggregation in diabetics].
    Carleo R; Buda GR; Cerciello A; Dell'Aversano R; Monaco GP; Trovato C; Vigilante M
    Boll Soc Ital Biol Sper; 1983 Dec; 59(12):1832-7. PubMed ID: 6671042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative randomized and placebo-controlled short-term trial of aspirin and dipyridamole for overt type-2 diabetic nephropathy.
    Khajehdehi P; Roozbeh J; Mostafavi H
    Scand J Urol Nephrol; 2002; 36(2):145-8. PubMed ID: 12028688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of low-dose oral sulodexide in the management of diabetic nephropathy.
    Blouza S; Dakhli S; Abid H; Aissaoui M; Ardhaoui I; Ben Abdallah N; Ben Brahim S; Ben Ghorbel I; Ben Salem N; Beji S; Chamakhi S; Derbel A; Derouiche F; Djait F; Doghri T; Fourti Y; Gharbi F; Jellouli K; Jellazi N; Kamoun K; Khedher A; Letaief A; Limam R; Mekaouer A; Miledi R; Nagati K; Naouar M; Sellem S; Tarzi H; Turki S; Zidi B; Achour A;
    J Nephrol; 2010; 23(4):415-24. PubMed ID: 20175052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tubular dysfunction in the early stage of diabetic nephropathy.
    Tanaka A; Shima K; Fukuda M; Tahara Y; Yamamoto Y; Kumahara Y
    Med J Osaka Univ; 1989 Mar; 38(1-4):57-63. PubMed ID: 2485397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. One year course of oral sulodexide in the management of diabetic nephropathy.
    Achour A; Kacem M; Dibej K; Skhiri H; Bouraoui S; El May M
    J Nephrol; 2005; 18(5):568-74. PubMed ID: 16299683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.